Elite Pharma Inc
(ELTP)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 03-2015 | 03-2014 | 03-2013 | 03-2012 | 03-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 5,221 | -41,261 | 1,488 | -15,058 | -13,582 |
| Depreciation Amortization | 582 | 454 | 423 | 484 | 484 |
| Accounts receivable | -714 | -67 | -268 | 175 | -167 |
| Other Working Capital | -843 | -63 | -900 | 372 | 660 |
| Other Operating Activity | -19,348 | 36,720 | -2,437 | 13,633 | 14,158 |
| Operating Cash Flow | $-15,103 | $-4,217 | $-1,693 | $-394 | $1,553 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,965 | -502 | -153 | -623 | -492 |
| Sale Of Investment | 5,000 | N/A | N/A | N/A | N/A |
| Purchase Sale Intangibles | N/A | -58 | -52 | -45 | -866 |
| Other Investing Activity | -156 | -55 | -39 | -35 | -863 |
| Investing Cash Flow | $2,879 | $-558 | $-192 | $-658 | $-1,355 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 54 | 529 | 600 | N/A | N/A |
| Debt Repayment | -1,110 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 14,038 | 10,868 | 565 | N/A | N/A |
| Other Financing Activity | -235 | -50 | 421 | -106 | 1,049 |
| Financing Cash Flow | $12,746 | $11,347 | $1,586 | $-106 | $1,049 |
| Beginning Cash Position | 6,942 | 369 | 668 | 1,826 | 578 |
| End Cash Position | 7,464 | 6,942 | 369 | 668 | 1,826 |
| Net Cash Flow | $522 | $6,573 | $-299 | $-1,158 | $1,248 |
| Free Cash Flow | |||||
| Operating Cash Flow | -15,103 | -4,217 | -1,693 | -394 | 1,553 |
| Capital Expenditure | -1,965 | -502 | -153 | -623 | -522 |
| Free Cash Flow | -17,068 | -4,719 | -1,846 | -1,017 | 1,031 |